Antibody-Drug Conjugates, ADCs
Category: Pharmaceutical
Exhibitor: TAIMED BIOLOGICS INC.
Booth No: M104
Characteristic
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the field of biological therapy. ADCs utilize monoclonal antibodies (mAbs) to specifically target antigens and deliver a highly potent cytotoxic agent to the tumor cell (for cancer treatment). After the ADCs are internalized, the cytotoxic drug is released and kills the cell. By this approach, the drug has fewer side effects and gives a wider therapeutic window than traditional cytotoxic agents. Although ADC technology is well-established as a superior treatment for cancer, its potential use in HIV treatment remains largely unexplored.
Other Products
Products you may be interested in
Highest Rated Products